Prognostic Impact Of Molecular Mutations In 182 Patients With Myelodysplastic Syndromes

被引：1
|
作者：
Kuendgen, Andrea
Seidler, Jenny
Lauseker, Michael
Haferlach, Torsten
Schnittger, Susanne
Kohlmann, Alexander
Hildebrandt, Barbara
Mueller-Thomas, Catharina
Betz, Beate
Haas, Rainer
Gattermann, Norbert
Royer-Pokora, Brigitte
Goetze, Katharina
Germing, Ulrich
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2758.2758
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2758
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Prognostic Impact of Rare Single Abnormalities in Myelodysplastic Syndromes
    Schanz, Julie
    Tuechler, Heinz
    Sole, Francesc
    Sanz, Guillermo
    Garcia-Manero, Guillermo
    Le Beau, Michelle M.
    Bennett, John M.
    Slovak, Marilyn L.
    Fenaux, Pierre
    Malcovati, Luca
    Cazzola, Mario
    Valent, Peter
    Ohyashiki, Kazuma
    Levis, Alessandro
    Sekeres, Mikkael A.
    Tauro, Sudhir
    Magalhaes, Silvia
    van de Loosdrecht, A. A.
    Cermak, Jaroslav
    Luebbert, Michael
    Stauder, Reinhard
    Hellstrom-Lindberg, Eva
    Gindina, Tatjana
    Germing, Ulrich
    Greenberg, Peter
    Haase, Detlef
    BLOOD, 2015, 126 (23)
  • [32] PROGNOSTIC IMPACT OF RAS PATHWAY GENE MUTATIONS IN PATIENTS WITH MYELODYSPLASIC SYNDROMES
    Martin-Izquierdo, Marta
    Lopez-Cadenas, Felix
    Jimenez-Aparicio, Teresa
    Hernandez-Sanchez, Jesus
    Lumbreras, Eva
    Ramos, Fernando
    Madinaveitia-Ochoa, Andres
    Olivier, Carmen
    Aguilar, Carlos
    Rodriguez, Juan Nicolas
    Rodriguez-Iglesias, Irene
    Gonzalez-Briones, Sara
    Santos-Minguez, Sandra
    Miguel-Garcia, Cristina
    Gutierrez, Vanesa
    Isidro, Isabel M.
    Benito, Rocio
    Abaigar, Maria
    Diez-Campelo, Maria
    Hernandez-Rivas, Jesus Maria
    HAEMATOLOGICA, 2020, 105 : 72 - 72
  • [33] Frequency and prognostic value of SF3B1 mutations in myelodysplastic syndromes and mixed myelodysplastic/myeloproliferative syndromes
    Saada, Veronique
    HEMATOLOGIE, 2012, 18 (01): : 13 - 15
  • [34] Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
    Rong He
    Jonathan Chiou
    Allison Chiou
    Dong Chen
    Constance P. Chen
    Caroline Spethman
    Kurt R. Bessonen
    Jennifer L. Oliveira
    Phuong L. Nguyen
    Kaaren K. Reichard
    James D. Hoyer
    Simon D. Althoff
    Dana J. Roh
    Mechelle A. Miller
    Ji Yuan
    Horatiu Olteanu
    Kebede Begna
    Ayalew Tefferi
    Hassan Alkhateeb
    Mrinal M. Patnaik
    Mark R. Litzow
    Aref Al-Kali
    David S. Viswanatha
    Blood Cancer Journal, 12
  • [35] Validation and improvement of the molecular international prognostic scoring system in Chinese patients with myelodysplastic syndromes
    Huang, Nanfang
    Song, Yang
    Wu, Lingyun
    He, Qi
    Zhang, Zheng
    Guo, Juan
    Xu, Feng
    Chang, Chunkang
    Li, Xiao
    ANNALS OF HEMATOLOGY, 2025, 104 (01) : 193 - 206
  • [36] Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
    He, Rong
    Chiou, Jonathan
    Chiou, Allison
    Chen, Dong
    Chen, Constance P.
    Spethman, Caroline
    Bessonen, Kurt R.
    Oliveira, Jennifer L.
    Nguyen, Phuong L.
    Reichard, Kaaren K.
    Hoyer, James D.
    Althoff, Simon D.
    Roh, Dana J.
    Miller, Mechelle A.
    Yuan, Ji
    Olteanu, Horatiu
    Begna, Kebede
    Tefferi, Ayalew
    Alkhateeb, Hassan
    Patnaik, Mrinal M.
    Litzow, Mark R.
    Al-Kali, Aref
    Viswanatha, David S.
    BLOOD CANCER JOURNAL, 2022, 12 (01)
  • [37] Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes
    Neukirchen-Strapatsas, Judith
    Tuechler, Heinz
    Della Porta, Matteo
    Fenaux, Pierre
    Guerci, Agnes
    Haas, Rainer
    Rossi, Marianna
    Sapena, Rosa
    Sperr, Wolfgang R.
    Strupp, Corinna
    Stamatoullas, Aspasia
    Valent, Peter
    Germing, Ulrich
    Bennett, John M.
    LEUKEMIA RESEARCH, 2019, 77 : 8 - 13
  • [38] Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)
    Cervera, J.
    Sole, F.
    Haase, D.
    Luno, E.
    Such, E.
    Nomdedeu, B.
    Costa, D.
    Bernal, T.
    Vallespi, T.
    Bueno, J.
    Pedro, C.
    Mallo, M.
    Ardanaz, M. T.
    Calasanz, M. J.
    del Canizo, C.
    Hernandez-Rivas, J. M.
    Schanz, J.
    Steidl, C.
    Hildebrandt, B.
    Carbonell, F.
    Orero, M.
    Ramos, F.
    Marco, V.
    Tormo, M.
    Gomez, V.
    Andreu, R.
    Xicoy, B.
    Amigo, M. L.
    Munoz, J. A.
    Bonanad, S.
    Arrizabalaga, B.
    Senent, M. L.
    Germing, U.
    Sanz, G. F.
    LEUKEMIA RESEARCH, 2009, 33 : S75 - S76
  • [39] The Impact of Somatic and Germline Mutations in Myelodysplastic Syndromes and Related Disorders
    Bejar, Rafael
    Greenberg, Peter L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (01): : 131 - 135
  • [40] Prognostic Impact of Molecular Mutations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) on Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes: Adverse Impact of TET2 Mutations
    Hamilton, Betty K.
    Majhail, Navneet S.
    Hirsch, Cassandra M.
    Przychodzen, Bartlomiej
    Rybicki, Lisa A.
    De Lima, Marcos
    Kalaycio, Matt
    Bolwell, Brian J.
    Gerds, Aaron T.
    Sobecks, Ronald
    Hanna, Rabi
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw P.
    BLOOD, 2015, 126 (23)
12345